This report contains market size and forecasts of Allogeneic Stem Cell Therapy in Global, including the following market information:
Global Allogeneic Stem Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Allogeneic Stem Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adult Stem Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Allogeneic Stem Cell Therapy include Escape Therapeutics, Inc., Lonza Group Ltd., Osiris Therapeutics (Smith & Nephew), NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Anterogen and MolMed S.p.A. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Allogeneic Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allogeneic Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others
Global Allogeneic Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others
Global Allogeneic Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Allogeneic Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allogeneic Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Allogeneic Stem Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)